BRPI0409049A - métodos de preparação de um composto, composição e composição cristalina - Google Patents
métodos de preparação de um composto, composição e composição cristalinaInfo
- Publication number
- BRPI0409049A BRPI0409049A BRPI0409049-7A BRPI0409049A BRPI0409049A BR PI0409049 A BRPI0409049 A BR PI0409049A BR PI0409049 A BRPI0409049 A BR PI0409049A BR PI0409049 A BRPI0409049 A BR PI0409049A
- Authority
- BR
- Brazil
- Prior art keywords
- formula
- composition
- compound
- preparing
- methods
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 4
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 2
- -1 5-oxo-3-pyrazolidinecarboxylate compound Chemical class 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 abstract 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 abstract 1
- OAKJQQAXSVQMHS-UHFFFAOYSA-N hydrazine Substances NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 abstract 1
- 150000002429 hydrazines Chemical class 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 239000002904 solvent Substances 0.000 abstract 1
- 150000003443 succinic acid derivatives Chemical class 0.000 abstract 1
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/06—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/48—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with two nitrogen atoms as the only ring hetero atoms
- A01N43/56—1,2-Diazoles; Hydrogenated 1,2-diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
- C09B67/00—Influencing the physical, e.g. the dyeing or printing properties of dyestuffs without chemical reactions, e.g. by treating with solvents grinding or grinding assistants, coating of pigments or dyes; Process features in the making of dyestuff preparations; Dyestuff preparations of a special physical nature, e.g. tablets, films
- C09B67/006—Preparation of organic pigments
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Agronomy & Crop Science (AREA)
- Plant Pathology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pest Control & Pesticides (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Dentistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Environmental Sciences (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
"MéTODOS DE PREPARAçãO DE UM COMPOSTO, COMPOSIçãO E COMPOSIçãO CRISTALINA". é descrito um método de preparação de um composto 5-oxo-3-pirazolidinocarboxilato 2-substituído da Fórmula I. O método compreende o contato de um derivado de ácido succínico da fórmula R¬ 1¬OC(O)C(H)(X)C(R¬ 2a¬)(R¬ 2b¬)C(O)Y (ou seja, Fórmula II), em que X e Y são grupos residuais e L, R¬ 1¬, R¬ 2a¬ e R¬ 2b¬ são conforme definido no relatório descritivo, com uma hidrazina substituída da fórmula LNHNH~ 2~ (ou seja, Fórmula III) na presença de um extrator de ácidos adequado e solvente. Também é descrita a preparação de compostos da Fórmula IV em que X¬ 1¬, R¬ 6¬, R¬ 7¬, R¬ 8¬, R¬ 8b¬, R¬ 9¬ e n são conforme definido no relatório descritivo. Também é descrita uma composição que compreende em base em peso cerca de 20 a 99% do composto da Fórmula II, em que R¬ 1¬, R¬ 2a¬, R¬ 2b¬, R¬ 3¬, R¬ 4¬ e R¬ 5¬ São conforme definido no relatório descritivo; X é CI, Br ou I; e Y é F, CI, Br ou I, desde que, quando R¬ 2a¬ e R¬ 2b¬ forem H cada um e X e Y forem CI cada um, R¬ 1¬ seja diferente de benzila e, quando R¬ 2a¬, e R¬ 2b¬ forem fenila cada um e X e Y forem CI cada um, R¬ 1¬ é diferente de metila ou etila. Também é descrita uma composição cristalina que compreende pelo menos cerca de 90% em peso do composto da fórmula R¬ 1¬OC(O)C(H)(X)C(R¬ 2a¬)(R¬ 2b¬)CO~ 2~H (ou seja, Fórmula VI) em que R¬ 2a¬ e R¬ 2b¬ são H cada um, X é Br e R¬ 1¬ é metila.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US45756103P | 2003-03-26 | 2003-03-26 | |
| PCT/US2004/009188 WO2004087689A1 (en) | 2003-03-26 | 2004-03-25 | Preparation and use of 2-substituted-5-oxo-3- pyrazolidinecarboxylates |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0409049A true BRPI0409049A (pt) | 2006-03-28 |
Family
ID=33131691
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0409049-7A BRPI0409049A (pt) | 2003-03-26 | 2004-03-25 | métodos de preparação de um composto, composição e composição cristalina |
Country Status (16)
| Country | Link |
|---|---|
| US (2) | US7442799B2 (pt) |
| EP (1) | EP1606276B1 (pt) |
| JP (1) | JP4750019B2 (pt) |
| KR (1) | KR101208748B1 (pt) |
| CN (1) | CN100522958C (pt) |
| AT (1) | ATE340791T1 (pt) |
| AU (1) | AU2004225981A1 (pt) |
| BR (1) | BRPI0409049A (pt) |
| DE (1) | DE602004002579T2 (pt) |
| DK (1) | DK1606276T3 (pt) |
| ES (1) | ES2274477T3 (pt) |
| IL (1) | IL169998A (pt) |
| PL (1) | PL1606276T3 (pt) |
| TW (1) | TWI367882B (pt) |
| WO (1) | WO2004087689A1 (pt) |
| ZA (1) | ZA200506096B (pt) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2343151C3 (ru) | 2003-01-28 | 2019-10-01 | ЭфЭмСи Корпорейшн | Цианоантраниламидные инсектициды |
| US7276601B2 (en) | 2003-06-12 | 2007-10-02 | E.I. Du Pont De Nemours And Company | Method and preparing fused oxazinones |
| ES2413442T3 (es) * | 2004-11-18 | 2013-07-16 | E. I. Du Pont De Nemours And Company | Insecticidas de antranilamida |
| AU2006283181A1 (en) * | 2005-08-24 | 2007-03-01 | E. I. Du Pont De Nemours And Company | Anthranilamides for controlling invertebrate pests |
| TWI415827B (zh) | 2006-12-21 | 2013-11-21 | Du Pont | 製備２-胺基-５-氰基苯甲酸衍生物之方法 |
| JP5495618B2 (ja) * | 2009-05-21 | 2014-05-21 | 国立大学法人 名古屋工業大学 | 光学活性トリフルオロメチル基含有化合物、その製造方法並びにそれを用いたトリフルオロメチル基含有光学活性アミン類の製造方法 |
| HUE025309T2 (en) | 2011-01-28 | 2016-01-28 | Du Pont | Process for the preparation of 2-aminobenzamide derivatives |
| EP2928471B1 (en) | 2012-12-06 | 2020-10-14 | Celgene Quanticel Research, Inc. | Histone demethylase inhibitors |
| CN106928183B (zh) * | 2015-12-29 | 2019-09-24 | 沈阳中化农药化工研发有限公司 | 吡啶基吡唑烷酮羧酸类化合物的制备方法 |
| CN106831705B (zh) * | 2016-12-28 | 2021-02-19 | 江苏扬农化工集团有限公司 | 一种吡啶基吡唑烷酮羧酸酯类化合物的合成方法 |
| CN109053726A (zh) * | 2018-09-14 | 2018-12-21 | 烟台万润药业有限公司 | 一种唑吡坦酸的制备方法 |
| AU2020334337A1 (en) * | 2019-08-21 | 2022-03-17 | Gharda Chemicals Limited | Process for synthesis of pyrazolidinone compounds |
| CN110483480A (zh) * | 2019-09-11 | 2019-11-22 | 江苏优普生物化学科技股份有限公司 | 2-(3-氯吡啶-2-基)-5-羟基-3-吡唑烷甲酸乙酯的合成方法 |
| CN111440144A (zh) * | 2020-03-06 | 2020-07-24 | 山东华科化工有限公司 | 一种微通道工业化生产溴代吡唑烷酸的方法 |
| CN111620850B (zh) * | 2020-05-27 | 2021-06-29 | 江苏七洲绿色化工股份有限公司 | 一种1-(3-氯吡啶-2-基)-3-溴-1h-吡唑-5-甲酸酯的制备方法 |
| US11529599B1 (en) | 2021-12-13 | 2022-12-20 | Cana Technology, Inc. | Electromechanical valve sequencing for fluid mixture dispensing devices |
| TW202342443A (zh) | 2022-01-31 | 2023-11-01 | 美商富曼西公司 | 用於製備３－溴－１－（３－氯吡啶－２－基）－４，５－二氫－１ｈ－吡唑－５－甲酸乙酯之方法 |
| WO2024049748A1 (en) | 2022-08-29 | 2024-03-07 | Fmc Corporation | A new and efficient process for preparing 3 -halo-4, 5-dihydro-1h-pyrazoles |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL279140A (pt) | 1961-05-31 | |||
| JPH01305071A (ja) | 1988-06-03 | 1989-12-08 | Nippon Oil Co Ltd | オキサゾロン誘導体の製造方法 |
| US5962523A (en) | 1996-10-25 | 1999-10-05 | Discovery Laboratories, Inc. | Methods of using butyric acid derivatives to protect against hair loss |
| ES2277838T3 (es) | 1999-05-18 | 2007-08-01 | Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. | Proceso para preparar r-(-)-carnitina a partir de acido s-(-)-clorosuccinico o a partir de un derivado del mismo. |
| TWI327566B (en) * | 2001-08-13 | 2010-07-21 | Du Pont | Novel substituted ihydro 3-halo-1h-pyrazole-5-carboxylates,their preparation and use |
| DE60236600D1 (de) * | 2001-08-13 | 2010-07-15 | Du Pont | Substituierte 1h-dihydropyrazole, ihre herstellung und verwendung |
| AR036872A1 (es) | 2001-08-13 | 2004-10-13 | Du Pont | Compuesto de antranilamida, composicion que lo comprende y metodo para controlar una plaga de invertebrados |
| TWI343376B (en) * | 2002-07-31 | 2011-06-11 | Du Pont | Method for preparing 3-halo-4, 5-dihydro-1h-pyrazoles |
-
2004
- 2004-03-09 TW TW093106257A patent/TWI367882B/zh not_active IP Right Cessation
- 2004-03-25 BR BRPI0409049-7A patent/BRPI0409049A/pt active Search and Examination
- 2004-03-25 DK DK04758355T patent/DK1606276T3/da active
- 2004-03-25 CN CNB2004800081395A patent/CN100522958C/zh not_active Expired - Lifetime
- 2004-03-25 WO PCT/US2004/009188 patent/WO2004087689A1/en active IP Right Grant
- 2004-03-25 EP EP04758355A patent/EP1606276B1/en not_active Expired - Lifetime
- 2004-03-25 ES ES04758355T patent/ES2274477T3/es not_active Expired - Lifetime
- 2004-03-25 JP JP2006509302A patent/JP4750019B2/ja not_active Expired - Fee Related
- 2004-03-25 AT AT04758355T patent/ATE340791T1/de active
- 2004-03-25 AU AU2004225981A patent/AU2004225981A1/en not_active Abandoned
- 2004-03-25 PL PL04758355T patent/PL1606276T3/pl unknown
- 2004-03-25 US US10/546,165 patent/US7442799B2/en active Active
- 2004-03-25 ZA ZA200506096A patent/ZA200506096B/en unknown
- 2004-03-25 DE DE602004002579T patent/DE602004002579T2/de not_active Expired - Lifetime
-
2005
- 2005-07-31 IL IL169998A patent/IL169998A/en not_active IP Right Cessation
- 2005-09-23 KR KR1020057017883A patent/KR101208748B1/ko not_active IP Right Cessation
-
2008
- 2008-09-19 US US12/234,063 patent/US7834186B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| WO2004087689A1 (en) | 2004-10-14 |
| ATE340791T1 (de) | 2006-10-15 |
| US20090036686A1 (en) | 2009-02-05 |
| ZA200506096B (en) | 2006-10-25 |
| DE602004002579T2 (de) | 2007-06-14 |
| TWI367882B (en) | 2012-07-11 |
| EP1606276A1 (en) | 2005-12-21 |
| CN1764658A (zh) | 2006-04-26 |
| KR20050114693A (ko) | 2005-12-06 |
| TW200504050A (en) | 2005-02-01 |
| AU2004225981A1 (en) | 2004-10-14 |
| DE602004002579D1 (de) | 2006-11-09 |
| CN100522958C (zh) | 2009-08-05 |
| US7442799B2 (en) | 2008-10-28 |
| PL1606276T3 (pl) | 2007-01-31 |
| JP2006521393A (ja) | 2006-09-21 |
| KR101208748B1 (ko) | 2012-12-05 |
| DK1606276T3 (da) | 2007-02-05 |
| US20070021468A1 (en) | 2007-01-25 |
| ES2274477T3 (es) | 2007-05-16 |
| EP1606276B1 (en) | 2006-09-27 |
| JP4750019B2 (ja) | 2011-08-17 |
| IL169998A (en) | 2011-07-31 |
| US7834186B2 (en) | 2010-11-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0409049A (pt) | métodos de preparação de um composto, composição e composição cristalina | |
| BR0211201A (pt) | Composto, processo para a preparação desse composto, sua utilização, composição farmacêutica que compreende o mesmo e método para o tratamento de uma enfermidade em um mamìfero | |
| RS51341B (en) | INTERMEDIATE COMPOUNDS FOR THE TRANS-5-CHLOR-2-METHYL-2,3A, 12B-TETRAHYDRO-1H-DIBENZE [2,3; 6,7] OXEPINO [4,5-C] Pyrrole | |
| CA2565660A1 (en) | Ortho substituted aryl or heteroaryl amide compounds | |
| NO990227L (no) | Heterocykliske forbindelser som farmas°ytika | |
| MA32249B1 (fr) | Dérivés polysubstitues de 2-heteroaryl-6-phenyl-imidazo[1,2- a]pyridines, leur préparation et leur application en thérapeutique | |
| WO2004089366A8 (en) | Bicyclic compounds as nr2b receptor antagonists | |
| AR041297A1 (es) | Derivados de 4-pirrolidino- fenil- bencil eter | |
| MA29653B1 (fr) | Nouveaux composes analogues de la camptothecine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent | |
| BRPI0511554A (pt) | composto ou um sal ou pró-droga farmaceuticamente aceitável do mesmo, método para produzir um efeito antibacteriano em um animal de sangue quente, uso de um composto ou de um sal farmaceuticamente aceitável, ou de um éster hidrolisável in vivo do mesmo, composição farmacêutica, e, processo para a preparação de um composto ou de um sal farmaceuticamente aceitável, ou de um éster hidrolisável in vivo do mesmo | |
| WO2006112742A3 (en) | PROCESS FOR PREPARATION OF 13,14-DIHYDRO-PGF2α DERIVATIVES | |
| MA29258B1 (fr) | Nouveaux derives d'oximes heterocycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent | |
| GEP20074256B (en) | Novel benzothiadiazine, process for their preparation and pharmaceutical compositions containing | |
| BRPI0415109A (pt) | compostos de 1-[2-(4-hidroxifenil)-2-hidroxietil]-piperidin-4-ol como antagonistas de receptor de nmda | |
| BR0308458A (pt) | Composto, composições fungicidas, método de controle de doenças vegetais e método de fabricação do composto | |
| AR062940A1 (es) | Compuestos para el tratamiento de desordenes metabolicos | |
| BRPI0413791A (pt) | composto, método para o tratamento de um indivìduo humano ou animal que sofre de, ou que é suscetìvel a um distúrbio auto-imune ou uma condição inflamatória, uso de um composto, composição farmacêutica, e, processo para a prearação de compostos | |
| NO973213L (no) | Nye 2-(1H)-quinolinforbindelser, fremgangsmåter ved fremstilling av slike samt farmasöytiske sammensetninger omfattende disse | |
| BRPI0414644A (pt) | composto, composições farmacêuticas, e, uso de um composto | |
| PT84560B (pt) | Processo para a preparacao de derivados dissimetricos do acido 1,4-di- -hidropiridino-3,5-dicarboxilico | |
| AR074629A1 (es) | Derivados de 1-bencil-cinolin-4-(1h)-ona sustituidos, su preparacion, composiciones farmaceuticas y su uso en el tratamiento de patologias asociadas con receptores de los cannabinoides cb2 | |
| HRP20000027B1 (en) | Process for the preparation of alkoxyfuranoneamine derivatives, compounds obtained by this process, and the use of these compounds | |
| EA200500716A1 (ru) | Новые соединения 2,3-дигидро-4-(1h)-пиридона, способ их получения и фармацевтические композиции, которые их содержат | |
| EP1619183A3 (en) | 1-amido-3-(2-hydroxyphenoxy)-2-propanol derivatives and a process for preparing 2-amidomethyl-1, 4-benzodioxane derivatives | |
| DE60335960D1 (de) | 1,2,4-triazolderivat, verfahren zu dessenherstellung, und dieses enthaltende pharmazeutische zusammensetzung |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B07G | Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette] |
Free format text: NOTIFICACAO DE DEVOLUCAO DO PEDIDO POR NAO SE ENQUADRAR NO ART. 229-C DA LPI. |
|
| B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 12A ANUIDADE. |
|
| B11D | Dismissal acc. art. 38, par 2 of ipl - failure to pay fee after grant in time |